"We also look forward to meeting with the FDA to h
Post# of 154897
(Total Views: 848)
Posted On: 09/08/2020 1:37:12 PM
"We also look forward to meeting with the FDA to help expedite the resubmission of our BLA, as well as learning whether we receive Emergency Use Approval for leronlimab for COVID-19 or, alternatively, are required to proceed with a Phase 3 trial." (CYDY PR)
So it seems to me CYDY should learn today if they get EUA or not in the US. I guess we'd see the price drop tomorrow if forced to do a phase 3, which would then potentially put the UK in the lead to grant an EUA and get the entire stock of leronlimab. No way the FDA could backtrack after saying they needed a phase 3.
PR after the market closes today or pre-market tomorrow? Thoughts?
So it seems to me CYDY should learn today if they get EUA or not in the US. I guess we'd see the price drop tomorrow if forced to do a phase 3, which would then potentially put the UK in the lead to grant an EUA and get the entire stock of leronlimab. No way the FDA could backtrack after saying they needed a phase 3.
PR after the market closes today or pre-market tomorrow? Thoughts?
(0)
(0)